Central Serous Chorioretinopathy

Common Name(s)

Central Serous Chorioretinopathy

Central serous chorioretinopathy is a disease that causes fluid to build up under the retina, the back part of the inner eye that sends sight information to the brain. The fluid leaks from the choroid (the blood vessel layer under the retina). The cause of this condition is unknown but stress can be a risk factor. Signs and symptoms include dim and blurred blind spot in the center of vision, distortion of straight lines and seeing objects as smaller or farther away. Many cases of central serous chorioretinopathy improve without treatment after 1-2 months. Laser treatment may be an option for other individuals.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Central Serous Chorioretinopathy" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Central Serous Chorioretinopathy" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Central Serous Chorioretinopathy" returned 236 free, full-text research articles on human participants. First 3 results:

Association of Central Serous Chorioretinopathy with Psychosocial Factors is Dependent on Its Phase and Subtype.
 

Author(s): Yong Kyu Kim, Se Joon Woo, Kyu Hyung Park, Yeon Kyung Chi, Ji Won Han, Ki Woong Kim

Journal: Korean J Ophthalmol. 2018 08;32(4):281-289.

 

To analyze the psychosocial factors associated with central serous chorioretinopathy (CSC) according to its phases and subtypes and to correlate the factors with the extent of choroidal hyperpermeability.

Last Updated: 31 Dec 1969

Go To URL
Commentary: Smoke stack leak on indocyanine green angiography in acute central serous chorioretinopathy.
 

Author(s): Chitaranjan Mishra

Journal: Indian J Ophthalmol. 2018 08;66(8):1183.

 

Last Updated: 31 Dec 1969

Go To URL
Smokestack leak on indocyanine green angiography in acute central serous chorioretinopathy.
 

Author(s): Apoorva Ayachit, Vinod Kumar, Nimmy Raj, Guruprasad Ayachit

Journal: Indian J Ophthalmol. 2018 08;66(8):1181-1182.

 

Last Updated: 31 Dec 1969

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Central Serous Chorioretinopathy" returned 14 free, full-text review articles on human participants. First 3 results:

Interventions for central serous chorioretinopathy: a network meta-analysis.
 

Author(s): Mahsa Salehi, Adam S Wenick, Hua Andrew Law, Jennifer R Evans, Peter Gehlbach

Journal:

 

Central serous chorioretinopathy (CSC) is characterized by serous detachment of the neural retina with dysfunction of the choroid and retinal pigment epithelium (RPE). The effects on the retina are usually self limited, although some people are left with irreversible vision loss due ...

Last Updated: 31 Dec 1969

Go To URL
Central Serous Chorioretinopathy Treatments: A Mini Review.
 

Author(s): Pierluigi Iacono, Maurizio Battaglia Parodi, Bruno Falcomatà, Francesco Bandello

Journal: Ophthalmic Res.. 2015 ;55(2):76-83.

 

Central serous chorioretinopathy (CSC) is a retinal disorder that primarily affects young (20- to 50-year-old) white men, although it is seen occasionally in older patients and females. CSC is characterized by avascular focal leakage through the retinal pigment epithelium (RPE), resulting ...

Last Updated: 31 Dec 1969

Go To URL
Photodynamic therapy and anti-vascular endothelial growth factor for acute central serous chorioretinopathy: a systematic review and meta-analysis.
 

Author(s): H Q Lu, E Q Wang, T Zhang, Y X Chen

Journal: Eye (Lond). 2016 Jan;30(1):15-22.

 

This systematic review aims to update current evidence on the efficacy and safety of photodynamic therapy (PDT) and anti-vascular endothelial growth factor (anti-VEGF) injections for acute central serous chorioretinopathy (CSC). A comprehensive literature search was conducted in PubMed, ...

Last Updated: 31 Dec 1969

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Brinzolamide for the Treatment of Chronic Central Serous Chorioretinopathy
 

Status: Not yet recruiting

Condition Summary: Central Serous Chorioretinopathy

 

Last Updated: 29 May 2018

Go to URL
Photodynamic Therapy Versus Eplerenone: Treatment Trial for Chronic Central Serous Chorioretinopathy
 

Status: Recruiting

Condition Summary: Chronic Central Serous Chorioretinopathy

 

Last Updated: 8 Mar 2018

Go to URL
The Changes of Retinal Capillaries After Half-dose PDT Measured by OCTA in Eyes With CSC
 

Status: Recruiting

Condition Summary: Central Serous Chorioretinopathy

 

Last Updated: 28 Sep 2018

Go to URL